Structure, signal transduction, activation, and inhibition of integrin αIIbβ3

• Published in: Thrombosis journal Vol. 21; no. 1; p. 18
• Main Authors: Xin, Honglei, Huang, Jiansong, Song, Zhiqun, Mao, Jianhua, Xi, Xiaodong, Shi, Xiaofeng
• Format: Journal Article Book Review
• Language: English
• Published: England BioMed Central 13-02-2023; BMC
• Subjects: Binding sites; Blood clots; Epidermal growth factor; Hemostasis; Integrins; Kinases; Ligands; Mutation; Platelet activation; Review; Signal transduction; Thrombosis; αIIbβ3; αIIbβ3; Platelet activation; Hemostasis; Thrombosis; Integrins
• ISSN: 1477-9560; 1477-9560
• DOI: 10.1186/s12959-023-00463-w

Integrins are heterodimeric receptors comprising α and β subunits. They are expressed on the cell surface and play key roles in cell adhesion, migration, and growth. Several types of integrins are expressed on the platelets, including αvβ3, αIIbβ3, α2β1, α5β1, and α6β1. Among these, physically αIIbβ3 is exclusively expressed on the platelet surface and their precursor cells, megakaryocytes. αIIbβ3 adopts at least three conformations: i) bent-closed, ii) extended-closed, and iii) extended-open. The transition from conformation i) to iii) occurs when αIIbβ3 is activated by stimulants. Conformation iii) possesses a high ligand affinity, which triggers integrin clustering and platelet aggregation. Platelets are indispensable for maintaining vascular system integrity and preventing bleeding. However, excessive platelet activation can result in myocardial infarction (MI) and stroke. Therefore, finding a novel strategy to stop bleeding without accelerating the risk of thrombosis is important. Regulation of αIIbβ3 activation is vital for this strategy. There are a large number of molecules that facilitate or inhibit αIIbβ3 activation. The interference of these molecules can accurately control the balance between hemostasis and thrombosis. This review describes the structure and signal transduction of αIIbβ3, summarizes the molecules that directly or indirectly affect integrin αIIbβ3 activation, and discusses some novel antiαIIbβ3 drugs. This will advance our understanding of the activation of αIIbβ3 and its essential role in platelet function and tumor development.